ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL secures contract for Medications Ravulizumab 300 Mg/3 Ml Sol Inj Fr 3 Ml Iv And Ravulizumab Inj 1100Mg/11Ml Iv

Portugal, Oct. 7 -- Portugal based ALEXION PHARMA SPAIN S L - SUCURSAL PORTUGAL has secured contract from Unidade Local De Saude De Santo Antonio, Epe for Medications Ravulizumab 300 Mg/3 Ml Sol Inj Fr 3 Ml Iv And Ravulizumab Inj 1100Mg/11Ml Iv. The value of the contract is 587599.86 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....